Monday, March 27, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

GREENEVILLE, Tenn. - King Pharmaceuticals sold itself too cheaply to Pfizer, for $3.6 billion or $14.25 a share, shareholders claim in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.